Serum cystatin C as a marker of renal function in detection of early acute kidney injury
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
In patients with acute kidney injury (AKI), serum creatinine level does not increase until moderate to severe reduction in glomerular filtration rate (GFR) occurs. Thus its use for estimating GFR in early AKI delays detection of kidney damage and making important therapeutic decisions. Moreover, serum cystatin C is not affected by gender, age, race, and muscle mass and also does not suffer from lag period for its rise in early AKI. We studied 200 healthy subjects and 130 AKI patients over a period of 2 years at a tertiary care hospital. Serum creatinine and serum cystatin C were studied and analyzed in relevance to early AKI. We found that 56.2% of patients of AKI group had normal levels of serum creatinine in early phase, while all patients had elevated serum cystatin C at same time. Multiple logistic regression analysis revealed cystatin C-based GFR reflecting decline in GFR with worsening AKI in better than creatinine-based GFR. Serum cystatin C is a better marker of renal function in early stages of AKI and is less affected by age, gender, muscle mass, and ethnicity. Its use helps in early therapeutic intervention and possibly favorable outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis
Dharnidharka, V. R., Kwon, C., & Stevens, G. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34487 · Cited by 1,663 · cited 1×
“Similar observations were found in many studies, especially in a meta‑analysis by Dharnidharka et al , [11] and Kyhse‑Andersen et al .”
ResultKnight, E. L., Verhave, J. C., Spiegelman, D., Hillege, H. L., De Zeeuw, D., Curhan, G. C., & De Jong, P. E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00517.x · Cited by 1,039 · cited 1×
“[10] Serum creatinine had higher standard deviation the, serum cystatin C in both subgroups AKI, and healthy, respectively.”
BackgroundFroissart, M., Rossert, J., Jacquot, C., Paillard, M., & Houillier, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070549 · Cited by 803 · cited 1×
“All 130 patients with AKI had deranged cystatin C levels [Table 3, Figure 1].”
BackgroundNewman, D. J., Thakkar, H., Edwards, R. G., Wilkie, M., White, T., Grubb, A. O., & Price, C. P. (1995) · Kidney International · doi:10.1038/ki.1995.40 · Cited by 650
Coll, E., Botey, A., Alvarez, L., Poch, E., Quintó, L., Saurina, A., Vera, M., Piera, C., & Darnell, A. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8237 · Cited by 642
Hoek, F. J. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg349 · Cited by 564
Kyhse-Andersen, J., Schmidt, C., Nordin, G., Andersson, B., Nilsson-Ehle, P., Lindström, V, & Grubb, A. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.10.1921 · Cited by 511 · cited 2×
“[4] In the AKI group, more than half the patients (56.2”
BackgroundMethodInfluential
Cited by
Zhao, W., Ammous, F., Ratliff, S., Liu, J., Yu, M., Mosley, T. H., Kardia, S. L. R., & Smith, J. A. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173141 · Cited by 113
Metadata
- Authors
- Murty, M. S. N., Sharma, U., Pandey, V., & Kankare, S.
- Venue
- Indian Journal of Nephrology
- Publisher
- Scientific Scholar
- Published
- 2013
- Volume
- 23
- Issue
- 3
- Pages
- 180
- ISSN
- 0971-4065 (ISSN-L)
- OpenAlex
- W1966514873
- Cited by
- 162
- References
- 14
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.